BREAKING
UP Fintech Holding Limited Reports Strong 2025 Results 3 hours ago FedEx (FDX) Q3 Earnings Crush Estimates: EPS of $5.25 Beats by 27% on $24B Revenue 3 hours ago Cato Corporation 2025 Financial Results Summary 4 hours ago GROY Posts Breakeven Q4 Earnings, Beating Estimates by 100% as Revenue Grows 34.2% YoY to $4.5M 4 hours ago York Space Systems (YSS) Posts -$0.24 EPS vs. -$0.18 Est., Revenue Soars to $105.3M 4 hours ago Scholastic (SCHL) Q3 Loss Narrows to $0.15/Share vs $0.36 Estimate, Revenue Misses at $329.1M 4 hours ago Curis (CRIS) EPS Soars 210.8% to $1.23, But Revenue Plunges 67.1% to $1.1M 4 hours ago Eton Pharmaceuticals (ETON) Q4 Revenue Surges 82.9% YoY to $21.3M, EPS Climbs 266.7% 4 hours ago Canadian Solar 2025 Financial Review 4 hours ago Intellicheck (IDN) EPS Soars 114.5% to $0.08, Crushing $0.03 Estimate on Revenue Growth 4 hours ago UP Fintech Holding Limited Reports Strong 2025 Results 3 hours ago FedEx (FDX) Q3 Earnings Crush Estimates: EPS of $5.25 Beats by 27% on $24B Revenue 3 hours ago Cato Corporation 2025 Financial Results Summary 4 hours ago GROY Posts Breakeven Q4 Earnings, Beating Estimates by 100% as Revenue Grows 34.2% YoY to $4.5M 4 hours ago York Space Systems (YSS) Posts -$0.24 EPS vs. -$0.18 Est., Revenue Soars to $105.3M 4 hours ago Scholastic (SCHL) Q3 Loss Narrows to $0.15/Share vs $0.36 Estimate, Revenue Misses at $329.1M 4 hours ago Curis (CRIS) EPS Soars 210.8% to $1.23, But Revenue Plunges 67.1% to $1.1M 4 hours ago Eton Pharmaceuticals (ETON) Q4 Revenue Surges 82.9% YoY to $21.3M, EPS Climbs 266.7% 4 hours ago Canadian Solar 2025 Financial Review 4 hours ago Intellicheck (IDN) EPS Soars 114.5% to $0.08, Crushing $0.03 Estimate on Revenue Growth 4 hours ago
ADVERTISEMENT
UTHR

United Therapeutics Corporation

$UTHR NASDAQ Feb 25, 2026 All Day

Investor Toolbox

Listen to Call

Recording not yet available.

Read Transcript

Transcript not yet available.

View Infographic

Infographic not yet available.

Earnings History

View past quarters and earnings trends.

View History

UTHR Coverage

Event United Therapeutics Corporation (UTHR) United Therapeutics Corporation Announces Full Results of TETON-2 Phase 3 Clinical Trial Published in The New England Journal of Medicine Mar 11, 2026 Transcript United Therapeutics Corporation (UTHR) Q4 2025 Earnings Call Transcript Mar 10, 2026 Event United Therapeutics Corporation (UTHR) Sec Form 8K Mar 10, 2026 Event United Therapeutics Corporation (UTHR) United Therapeutics Corporation Announces $2 Billion Stock Repurchase Authorization and Enters into $1.5 Billion Accelerated Share Repurchase Program Mar 9, 2026 Transcript United Therapeutics Corporation (UTHR) Q2 2025 Earnings Call Transcript Jan 22, 2026 Transcript United Therapeutics Corporation (UTHR) Q3 2025 Earnings Call Transcript Jan 22, 2026